Ipamorelin With Coa
In analytical and preclinical research, experimental validity depends on compound identity, chemical purity, and the absence of biological contaminants. Securing research-grade Ipamorelin with a lot-specific Certificate of Analysis (COA) guarantees that quantitative measurements reflect true peptide activity rather than baseline artifacts or impurities.
Quick answer
In analytical and preclinical research, experimental validity depends on compound identity, chemical purity, and the absence of biological contaminants. Securing research-grade Ipamorelin with a lot-specific Certificate of Analysis (COA) guarantees that quantitative measurements reflect true peptide activity rather than baseline artifacts or impurities.
Key takeaways
- An [Ipamorelin](/research-peptides/ipamorelin) [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) is an essential quality assurance document issued by an independent ISO 17025 accredited laboratory that verifies the exact identity, purity, and safety profile of a specific peptide lot.
- [Ipamorelin](/research-peptides/ipamorelin) is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2.
- In preclinical animal models, [Ipamorelin](/research-peptides/ipamorelin) exhibits a distinct pharmacokinetic profile characterized by rapid receptor association and a transient spike in plasma growth hormone concentration.
- Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the primary analytical method used to quantify the chemical purity of synthetic peptides.
What is an Ipamorelin Certificate of Analysis (COA)?
An Ipamorelin Certificate of Analysis (COA) is an essential quality assurance document issued by an independent ISO 17025 accredited laboratory that verifies the exact identity, purity, and safety profile of a specific peptide lot. A complete COA for Ipamorelin provides quantitative evidence of purity via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), exact molecular weight identification via Electrospray Ionization Mass Spectrometry (ESI-MS), and bacterial endotoxin quantification via the Limulus Amebocyte Lysate (LAL) assay.
Without an authentic, lot-matched COA, investigators risk introducing uncontrolled variables into cell culture assays or animal models. Unidentified baseline peaks in chromatography or elevated endotoxin levels can induce non-specific cellular stress, skewing transcription profiles, receptor binding assays, and endocrine response measurements. Researchers evaluating growth hormone secretagogues can review verified documentation directly through the PX1 Research catalog to ensure complete experimental integrity.
Molecular Structure and Mechanism of Action
Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. It belongs to the class of growth hormone secretagogues (GHS) and acts as a potent, selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Unlike earlier generation hexapeptides, Ipamorelin was rationalized through structure-activity relationship (SAR) studies to isolate growth hormone stimulation from secondary neuroendocrine cascades.
When bound to the GHS-R1a receptor, Ipamorelin triggers a G-protein-coupled intracellular signaling cascade, inducing phospholipase C activation, inositol triphosphate (IP3) production, and subsequent intracellular calcium mobilization within somatotropic cells. This signal transduction pathway stimulates the exocytosis of storage vesicles containing endogenous growth hormone. Investigators studying receptor selectivity frequently compare these pathways against other research peptides to map binding kinetics and signal amplification.
Preclinical Literature on Pulsatile GH Secretion
In preclinical animal models, Ipamorelin exhibits a distinct pharmacokinetic profile characterized by rapid receptor association and a transient spike in plasma growth hormone concentration. Rodent and porcine studies demonstrate that administration of Ipamorelin induces a robust, pulsatile release of growth hormone that closely mimics physiological baseline pulses.
Crucially, preclinical data indicate that Ipamorelin achieves this somatotropic response without eliciting significant increases in adrenocorticotropic hormone (ACTH), cortisol, or prolactin levels. In comparative in vitro pituitary cell assays, while older peptides like GHRP-2 and GHRP-6 demonstrated dose-dependent elevations in cortisol and prolactin, Ipamorelin maintained high selectivity for GH release across wide dosage curves. This functional selectivity makes the compound a valuable tool for isolating somatotrophic pathways without confounding steroidogenic or lactotrophic crosstalk.
Deconstructing the COA: RP-HPLC Purity Analysis
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the primary analytical method used to quantify the chemical purity of synthetic peptides. In an HPLC chromatogram for Ipamorelin, the primary compound produces a sharp, distinct peak at a specific retention time determined by its hydrophobic interactions with the stationary C18 phase.
Purity is expressed as a peak area percentage, calculated by dividing the integrated area of the primary peptide peak by the total area of all detected peaks in the run. High-purity research materials must exhibit an HPLC purity exceeding 98.0% or 99.0%. Minor secondary peaks represent synthesis deletion sequences, truncated peptides, or oxidation products. Examining the raw HPLC chromatogram on a COA allows researchers to confirm that total impurities remain well below strict analytical thresholds.
Mass Spectrometry: Confirming Molecular Identity
While HPLC measures purity and separates chemical species, it cannot definitively confirm molecular identity. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) is required to measure the exact mass-to-charge ratio (m/z) of the molecule.
The theoretical monoisotopic molecular weight of Ipamorelin is 711.86 g/mol. On a mass spectrometry report included within a verified COA, the observed spectrum should display a dominant mass peak corresponding to the protonated species ([M+H]+ at ~712.9 m/z) or multiply charged species. Matching the experimentally observed molecular weight to the theoretical mass confirms that the peptide sequence was correctly assembled during solid-phase peptide synthesis (SPPS) without amino acid substitutions or unintended protecting group retention.
Bacterial Endotoxin Protocols and LAL Testing
Endotoxins are lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria that can contaminate synthetic compounds during manufacturing or purification. In cellular and preclinical research, elevated endotoxin levels induce inflammatory responses via Toll-like receptor 4 (TLR4) activation, leading to cytokine release and potential cytotoxicity that invalidates experimental outcomes.
A rigorous COA must include quantitative endotoxin testing conducted via the Limulus Amebocyte Lysate (LAL) assay, typically reported in Endotoxin Units per milligram (EU/mg). Research-grade compounds provided by PX1 Research undergo stringent purification steps to achieve endotoxin thresholds well below 0.05 EU/mg, ensuring that in vitro and animal models remain free from LPS-induced immunological interference.
Comparative Analysis: Growth Hormone Secretagogues
To select the appropriate tool for endocrine research, investigators must understand how Ipamorelin compares to alternative secretagogues within the same functional category. The table below outlines key analytical and functional differences across widely studied compounds:
When compared to compounds such as GHRP-2 or GHRP-6, Ipamorelin stands out for its minimal interaction with non-target receptors. While GHRP-2 and GHRP-6 display high affinity for GHS-R1a, they also stimulate ghrelin-mediated appetite centers and systemic cortisol release in rodent models. Conversely, GHRH analogs like Sermorelin or CJC-1295 No DAC act on the Growth Hormone Releasing Hormone receptor (GHRHR) rather than GHS-R1a. Combining a GHS-R1a agonist like Ipamorelin with a GHRHR agonist is a frequent focus of preclinical synergy studies exploring dual-receptor somatotroph activation.
Laboratory Reconstitution and Storage Guidance
Ipamorelin is supplied as a lyophilized (freeze-dried) powder to maximize long-term peptide stability. For laboratory handling, lyophilized vials should be stored at -20°C or -80°C in a desiccated environment to prevent moisture absorption and enzymatic degradation.
Reconstitution should be performed under a laminar flow hood using sterile laboratory reagents, such as bacteriostatic water or sterile phosphate-buffered saline (PBS), depending on the requirements of the downstream assay. Solvent should be added gently down the side of the glass vial to avoid mechanical shearing of the peptide structure. Once reconstituted, liquid solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles and stored at 2°C to 8°C for short-term evaluation or -80°C for extended experimental timelines.
PX1 Research Sourcing and Quality Verification Standards
PX1 Research enforces comprehensive quality control standards for all research peptides. Every batch of Ipamorelin is manufactured in state-of-the-art facilities compliant with Good Manufacturing Practice (GMP) standards within the United States. Following synthesis and purification, independent testing is executed by third-party ISO 17025 accredited analytical laboratories.
Every product page provides direct access to lot-matched COAs displaying authentic HPLC chromatograms, mass spectra, and LAL endotoxin data. For academic institutions, biotech firms, and contract research organizations needing bulk quantities or custom specifications, PX1 Research offers flexible supply arrangements through our wholesale lab program. Orders are dispatched directly from our dual logistics centers in California and Arizona with same-day shipping (Monday–Friday) to ensure rapid delivery for time-sensitive research projects.
Frequently Asked Questions
What information should be listed on an Ipamorelin COA?
A complete Certificate of Analysis for Ipamorelin should detail the product lot number, chemical name, sequence, theoretical and observed molecular weights (via ESI-MS), purity percentage with an accompanying RP-HPLC chromatogram, appearance, mass balance, and quantitative bacterial endotoxin levels (via LAL assay).
Why is RP-HPLC purity important for in vitro research?
Unpurified or low-purity peptides contain truncated amino acid sequences and chemical reagents leftover from synthesis. These impurities can bind non-specifically to cell receptors, cause cytotoxicity, or skew quantitative assays, leading to non-reproducible research findings.
How does mass spectrometry verify Ipamorelin identity?
Mass spectrometry measures the precise mass-to-charge ratio of the peptide molecules. By matching the observed mass peak to Ipamorelin's theoretical molecular weight of 711.86 g/mol, the assay confirms correct amino acid assembly and total sequence integrity.
What is an acceptable endotoxin limit for research peptides?
For sensitive cell culture assays and animal models, endotoxin levels should ideally fall below 0.1 EU/mg, with premium research grade materials achieving levels under 0.05 EU/mg to prevent inflammatory signaling via TLR4 receptor pathways.
Does Ipamorelin raise cortisol or prolactin in preclinical models?
Preclinical studies show that Ipamorelin is highly selective for the GHS-R1a receptor and does not induce statistically significant elevations in ACTH, cortisol, or prolactin levels, unlike older hexapeptide secretagogues.
How should lyophilized Ipamorelin be stored upon arrival?
Upon receipt, lyophilized Ipamorelin vials should be stored at -20°C or -80°C in a dry environment shielded from light to preserve peptide stability prior to reconstitution.
What solvent is recommended for reconstituting Ipamorelin for lab use?
Depending on the experimental protocol, common solvents include sterile bacteriostatic water, sterile 0.9% saline, or cell-culture grade PBS. Solvents should be chosen based on assay compatibility and required shelf life.
Where are PX1 Research peptides manufactured and tested?
All PX1 Research peptides are manufactured in US-based GMP-compliant facilities and undergo rigorous third-party testing at independent ISO 17025 accredited laboratories.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.